Genmab A/S Price Target Raised to $39.57
Genmab A/S's 12-month price target was raised to $39.57, implying a 15% upside.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.